Covid-19 disease and its impact on NET therapy (incl. somatostatin receptor targeted therapies)

Covid-19 disease and its impact on NET therapy (incl. somatostatin receptor targeted therapies)

Moderators: Marianne Ellen PAVEL

Introduction agenda and speakers
      Panel: Wouter DE HERDER and John RAMAGE

General aspects of management of NEN patients in the COVID-19 era

COVID-19 and its impact on somatostatin receptor targeted therapies, including the use of SSA and the use of PRRT

Closing comments

Keywords: